The hub expands the company's research and development footprint in the region and hastens the development of AI-powered digital health technologies.
The General Catalyst Institute, launched in the U.S. in September, is expanding into India and inviting policymakers and entrepreneurs in the region to collaborate.
They will collaborate on identifying novel therapeutic drug candidates for lung cancer.
The aim is to allow clinicians to transition between several therapeutic environments to optimize treatment outcomes.
The alliance will provide members with proactive, user-friendly remote monitoring capabilities.
The companies developed a five-episode video series to give guests and members tips on enhancing sleep quality when they're on the go.
The company will use the funds to expand its AI-enabled platform and create additional partnerships with payor organizations.
The partnership will give AeroFlow customers access to DME prescriptions.
The company will use the funds to strengthen its research and development capabilities.
The health management company will integrate Ubie's symptom checker into its platform to support patients from symptom onset through treatment.
